Arrowhead Pharmaceuticals Inc (ARWR)
R&D Expenses
$723.37M
TTM · Period ending: · USD
ARWR R&D Expenses
Latest reported$723.37Mperiod ending
Latest reported$723.37Mperiod ending
ARWR R&D Expenses ($0.00 → $723.37M)
Annual R&D Expenses
High-resolution chart · PNG
ARWR r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 607,159,000 | |
| 489,216,000 | |
| 342,312,000 | |
| 288,500,000 | |
| 206,342,000 | |
| 123,543,716 | |
| 76,628,541 | |
| 48,296,230 | |
| 46,252,027 | |
| 41,454,452 | |
| 47,267,361 | |
| 23,138,050 | |
| 8,705,627 | |
| 5,391,463 | |
| 3,277,760 | |
| 857,409 | |
| 6,207,157 | |
| 8,309,556 | |
| 10,935,643 | |
| 8,582,019 | |
| 3,793,377 | |
| 793,354 | |
| 3,375 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |